STERIS plc Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
STERIS plc (STE) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$14.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-07
- STERIS plc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$14.10M, a 106.36% decline year-over-year.
- STERIS plc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$70.40M, a 185.96% decline year-over-year.
- STERIS plc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $33.40M.
- STERIS plc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$5.60M, a 103.56% decline year-over-year.
- STERIS plc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2026 was $179.20M, a 393.66% increase from fiscal 2025.
- STERIS plc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $36.30M.
- STERIS plc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$7.90M.
- STERIS plc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$110.90M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$14.10M 10-Q · filed 2026-08-07 | -$84.50M derived: sum of 2 quarters · filed 2026-08-07 | -$51.10M derived: sum of 3 quarters · filed 2026-08-07 | -$56.70M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$70.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | -$37.00M derived: sum of 2 quarters · filed 2026-05-29 | -$42.60M derived: sum of 3 quarters · filed 2026-05-29 | $179.20M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $33.40M 10-Q · filed 2026-02-06 | $27.80M derived: sum of 2 quarters · filed 2026-02-06 | $249.60M 10-Q · filed 2026-02-06 | $331.50M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | -$5.60M 10-Q · filed 2025-11-06 | $216.20M 10-Q · filed 2025-11-06 | $298.10M derived: sum of 3 quarters · filed 2026-08-07 | $89.70M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $221.80M 10-Q · filed 2026-08-07 | $303.70M derived: sum of 2 quarters · filed 2026-08-07 | $95.30M derived: sum of 3 quarters · filed 2026-08-07 | $252.50M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $81.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | -$126.50M derived: sum of 2 quarters · filed 2026-05-29 | $30.70M derived: sum of 3 quarters · filed 2026-05-29 | $36.30M 10-K · filed 2026-05-29 | $36.32M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | -$208.40M 10-Q · filed 2026-02-06 | -$208.41M 10-Q · filed 2025-02-07 | -$51.20M derived: sum of 2 quarters · filed 2026-02-06 | -$45.60M 10-Q · filed 2026-02-06 | -$45.59M 10-Q · filed 2025-02-07 | -$121.58M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-09-30 | $157.20M 10-Q · filed 2025-11-06 | $157.23M 10-Q · filed 2024-11-07 | $162.80M 10-Q · filed 2025-11-06 | $162.82M 10-Q · filed 2024-11-07 | $86.82M derived: sum of 3 quarters · filed 2026-05-29 | $220.93M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-06-30 | $5.60M 10-Q · filed 2025-08-07 | $5.59M 10-Q · filed 2024-08-08 | -$70.38M derived: sum of 2 quarters · filed 2026-05-29 | $63.73M derived: sum of 3 quarters · filed 2026-05-29 | -$12.15M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | -$75.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $58.13M derived: sum of 2 quarters · filed 2026-05-29 | -$17.75M derived: sum of 3 quarters · filed 2026-05-29 | -$7.90M 10-K · filed 2026-05-29 | -$7.95M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $134.11M 10-Q · filed 2025-02-07 | $58.23M derived: sum of 2 quarters · filed 2025-02-07 | $68.08M 10-Q · filed 2025-02-07 | $111.53M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-09-30 | -$75.88M 10-Q · filed 2024-11-07 | -$66.03M 10-Q · filed 2024-11-07 | -$22.57M derived: sum of 3 quarters · filed 2025-05-29 | $211.41M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-06-30 | $9.85M 10-Q · filed 2024-08-08 | $53.30M derived: sum of 2 quarters · filed 2025-05-29 | $287.29M derived: sum of 3 quarters · filed 2025-05-29 | $77.51M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-03-31 | $43.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $277.44M derived: sum of 2 quarters · filed 2025-05-29 | $67.66M derived: sum of 3 quarters · filed 2025-05-29 | -$110.90M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | $233.99M 10-Q · filed 2024-02-08 | $24.21M derived: sum of 2 quarters · filed 2024-02-08 | -$154.35M 10-Q · filed 2024-02-08 | -$227.28M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | -$209.78M 10-Q · filed 2023-11-07 | -$388.34M 10-Q · filed 2023-11-07 | -$461.27M derived: sum of 3 quarters · filed 2024-05-29 | -$492.42M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | -$178.56M 10-Q · filed 2023-08-08 | -$251.50M derived: sum of 2 quarters · filed 2024-05-29 | -$282.64M derived: sum of 3 quarters · filed 2024-05-29 | -$351.56M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | -$72.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | -$104.08M derived: sum of 2 quarters · filed 2024-05-29 | -$172.99M derived: sum of 3 quarters · filed 2024-05-29 | -$148.56M 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | -$31.14M 10-Q · filed 2023-02-08 | -$100.06M derived: sum of 2 quarters · filed 2023-02-08 | -$75.64M 10-Q · filed 2023-02-08 | -$134.49M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | -$68.92M 10-Q · filed 2022-11-09 | -$44.49M 10-Q · filed 2022-11-09 | -$103.35M derived: sum of 3 quarters · filed 2023-05-26 | $24.88M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $24.43M 10-Q · filed 2022-08-08 | -$34.43M derived: sum of 2 quarters · filed 2023-05-26 | $93.80M derived: sum of 3 quarters · filed 2023-05-26 | $171.54M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | -$58.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $69.37M derived: sum of 2 quarters · filed 2023-05-26 | $147.11M derived: sum of 3 quarters · filed 2023-05-26 | $174.22M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $128.23M 10-Q · filed 2022-02-09 | $205.97M derived: sum of 2 quarters · filed 2022-02-09 | $233.08M 10-Q · filed 2022-02-09 | $146.54M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $77.74M 10-Q · filed 2021-11-08 | $104.85M 10-Q · filed 2021-11-08 | $18.31M derived: sum of 3 quarters · filed 2022-05-31 | $95.10M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | $27.11M 10-Q · filed 2021-08-09 | -$59.43M derived: sum of 2 quarters · filed 2022-05-31 | $17.36M derived: sum of 3 quarters · filed 2022-05-31 | -$51.51M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | -$86.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | -$9.75M derived: sum of 2 quarters · filed 2022-05-31 | -$78.62M derived: sum of 3 quarters · filed 2022-05-31 | -$75.69M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $76.80M 10-Q · filed 2021-02-09 | $7.92M derived: sum of 2 quarters · filed 2021-02-09 | $10.86M 10-Q · filed 2021-02-09 | $18.10M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | -$68.87M 10-Q · filed 2020-11-06 | -$65.94M 10-Q · filed 2020-11-06 | -$58.69M derived: sum of 3 quarters · filed 2021-05-28 | -$98.94M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $2.93M 10-Q · filed 2020-08-07 | $10.18M derived: sum of 2 quarters · filed 2021-05-28 | -$30.06M derived: sum of 3 quarters · filed 2021-05-28 | -$35.75M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | -$33.00M derived: sum of 2 quarters · filed 2021-05-28 | -$38.68M derived: sum of 3 quarters · filed 2021-05-28 | -$169.49M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | -$40.24M 10-Q · filed 2020-02-10 | -$45.93M derived: sum of 2 quarters · filed 2020-02-10 | -$176.74M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | -$5.68M 10-Q · filed 2019-11-07 | -$136.50M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | -$130.81M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $252.39M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | -$172.54M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |